FDA 483 - Bridge to Life - June 27, 2025

An FDA inspection of Bridge to Life, a specification developer in Columbia, SC, identified one significant observation. The firm failed to perform design validation under actual or simulated use conditions for its (b)(4) cold storage solution, a Class II medical device. This indicates a deficiency in their design control processes.